KRM Ayurveda IPO: GMP, Price, Analysis, And Details

KRM Ayurveda IPO- Company Analysis

KRM Ayurveda IPO under the SME IPO category is a bookbuild issue of Rs. 77.49 Cr by KRM Ayurveda Limited and is running multiple clinics and hospitals in a range of cities in India. Plus, abroad using telemedicine for consulting and sales.

They sell Ayurvedic products, herbal remedies, botanical remedies, dietary supplements, and possibly skin care and wellness products. Currently, the company has 6 hospitals and 5 clinics across different locations in the country.

The hospitals and clinics have the following facilities and infrastructure:

• Beds, General wards and premium rooms.

• Units for panchakarma treatments.

• A unit for herbal pharmacy and preparation of medicines.

• Ayurvedic diet kitchen.

• Consultation rooms for Vaidyas (Ayurvedic doctors).

• A yoga and meditation hall.

The following services are provided:

• In-Patient & Out-Patient Care

• Panchakarma Therapies

• Specialised Clinics

• Wellness Packages

• Sale of Medicines

• Diet & Lifestyle Counselling.

KRM Ayurveda IPO Details

The KRM Ayurveda IPO date of opening is 19 Jan 2026, its initial public offering will end on 21 Jan, IPO allotment on Jan 22 and refund initiation on Jan 23, 2026.

The Rs. 77.49 crore new SME IPO comprises a wholly fresh issue of 0.57 crore shares.

The KRM Ayurveda IPO listing date (expected) might be on Tuesday, Jan 27, 2026, and listing at the NSE and SME. 

The KRM Ayurveda IPO price band is Rs. 128 to Rs. 135.

IPO Timetable (Tentative)

Events	Date
IPO Opening Date	Jan 19, 2026
IPO Closing Date	Jan 21, 2026
IPO Allotment Date	Jan 22, 2026
Refund Initiation	Jan 23, 2026
IPO Listing Date	Jan 27, 2026

 

Click to open demat account and apply for the IPO.

 

Company Financials

(Amount in Cr)

Particulars	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	66.79	43.91	39.48
Total Income	76.95	67.57	89.38
PAT	12.10	3.41	7.60
EBITDA	19.11	7.34	11.03
Net Worth	23.88	11.78	8.37
Reserves & Surplus	23.73	11.63	8.22
Total Borrowing	31.20	23.18	19.87

 

Cash Flows

(Amount in lac)

Net Cash Flow	31 Mar 2025	31 Mar 2024	31 Mar 2023
Net Cash Flow Operating Activities	(2.86)	(89.46)	350.92
Net Cash Flow Investing Activities	(433.51)	(12.61)	(2,293.84)
Net Cash Flow Financing Activities	590.08	129.38	1,947.45

 

Revenue Bifurcation

(Rs. in Lac)

(Source: RHP)

The Objective of the Issue

The company desires to use the Net Proceeds from the Issue to fulfill its following goals:

• Capital expenditure for the construction and development of telemedicine operational facilities. ~ Rs. 13.67 Cr

• Purchase of CRM Software and Hardware Infrastructure. ~ Rs. 1.42 Cr.

• Human Resources. ~ Rs. 5.44 Cr.

• Repayment/Prepayment of loan. ~ Rs. 12.50 Cr.

• Working Capital Requirement. ~ Rs. 22.90 Cr.

• General Corporate Purposes.
  
  

Listed Peers of KRM Ayurveda Ltd.

Name of the Company	Face Value (₹)	EPS (₹)	P/E Ratio (x)
Jeena Sikho Lifecare Ltd.	2	8.86	76.58
Vaidya Sane Ayurved Laboratories Ltd	10	3.07	93.20

 

Valuation

KPI	Value
ROE	67.86%
ROCE	43.33%
Debt / Equity	1.31
RoNW	67.86%
PAT Margin	15.80%
EBITDA Margin	24.96%
Price to Book Value	0.08

 

 

Evaluation of P/E Ratio

Considering the period ended on FY 2025 with an EPS of Rs. 8.06 from the last year, the resulting P/E ratio is 16.74.

Explore the Bai Kakaji Polymers IPO.

IPO's Strengths

• High-quality care is guaranteed by qualified therapists and skilled Ayurvedic physicians.

• The potency and purity of Ayurvedic drugs are ensured by their central production under GMP certification.

• Dependable company with a devoted following of repeat customers.
  
  

IPO’s Weaknesses

• Operational complexity in maintaining uniform quality at several places.

• Reliance on the availability of raw materials and high-quality herbs.

• In certain recently targeted areas, there is little brand awareness.

 

KRM Ayurveda IPO GMP (Grey Market Premium)

KRM Ayurveda IPO GMP today is Rs. 15 as of 16 Jan 2026 while writing this information. With a price band set at Rs. 135. This suggests that the estimated listing price of the IPO could be around Rs. 150, indicating a gain/loss of 11.11%.

KRM Ayurveda IPO Summary

IPO Opening & Closing Date	19 Jan, 2026 to 21 Jan, 2026
Face Value	Rs. 10 per Share
Issue Price	Rs. 128 to Rs. 135 per Share.
Lot Size	1000 Shares
Issue Size	57,40,000 Shares (Rs. 77 Cr)
Offer for Sale	-
Fresh Issue	57,40,000 Shares (Rs. 77 Cr)
Listing at	NSE, SME
Issue Type	Bookbuild issue IPO
Registrar	Skyline Financial Services Pvt. Ltd.

IPO Lot Details 

Retail investors can invest in a minimum of 2 Lots (2000 Shares) for Rs. 2,70,000, and in multiples thereof, while HNI investors can invest in a minimum of 3 Lots (3000 Shares) for Rs. 4,05,000.

Minimum Lot Investment (Retail)	2 Lots
Maximum Lot Investment (Retail)	2 Lots
HNI (Min)	3 Lots

 

KRM Ayurveda IPO Allotment Status

To check the KRM Ayurveda IPO Allotment Status, visit the official Registrar’s website or BSE website. Below are the website links for you.

Using BSE Website - ​BSE IPO allotment status

Promoters And Management of KRM Ayurveda Ltd.

• Mr. Puneet Dhawan 

• Mrs. Tanya Dhawan

Pre-Issue Promoter Shareholding	92.16%
Post-Issue Promoter Shareholding	67.28%

 

IPO Lead Managers

• NEXGEN Financial Solutions Pvt. Ltd. 
  
  

Dividend Policy

The company has not paid a dividend during the last three financial years.

 

Conclusion

The SME book-build KRM Ayurveda IPO has a scalable Ayurvedic healthcare + telemedicine business model, robust financial growth, and an appealing FY25 P/E value. The company is a growth-oriented SME IPO to monitor because of its increasing profitability, growing clinics, and emphasis on digital healthcare. However, before submitting an application for a long-term investment, investors should consider operational risks and debt levels.

 

Finowings IPO Analysis

Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO. 

You must consult your financial advisor before making any financial decisions. 

To Apply for the IPO, Click Here.

To Read the Prospectus of the Company Click Here to Download the DRHP.

Click Here To Stay Updated With The Upcoming IPOs.

DISCLAIMER: This blog is NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always consult your eligible financial advisor for investment-related decisions.